INMODE LTD IS -01 (F:154) — Market Cap & Net Worth

$834.35 Million USD  · €713.67 Million EUR  · Rank #9944

Market Cap & Net Worth: INMODE LTD IS -01 (154)

INMODE LTD IS -01 (F:154) has a market capitalization of $834.35 Million (€713.67 Million) as of May 5, 2026. Listed on the F stock exchange, this Germany-based company holds position #9944 globally and #1188 in its home market, demonstrating a -4.17% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying INMODE LTD IS -01's stock price €11.71 by its total outstanding shares 63209152 (63.21 Million).

INMODE LTD IS -01 Market Cap History: 2022 to 2026

INMODE LTD IS -01's market capitalization history from 2022 to 2026. Data shows change from $2.44 Billion to $865.35 Million (-23.90% CAGR).

INMODE LTD IS -01 Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how INMODE LTD IS -01's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

No P/S ratio data available

Latest Price to Earnings (P/E) Ratio

No P/E ratio data available

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
No financial ratio data available

Competitor Companies of 154 by Market Capitalization

Companies near INMODE LTD IS -01 in the global market cap rankings as of May 5, 2026.

Key companies related to INMODE LTD IS -01 by market ranking:

  • Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
  • Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
  • Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
  • Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#141 Abbott Laboratories NYSE:ABT $155.56 Billion $89.46
#208 Stryker Corporation NYSE:SYK $112.79 Billion $294.73
#230 Medtronic plc SA:MDTC34 $104.84 Billion R$208.39
#236 Medtronic PLC NYSE:MDT $102.56 Billion $80.00

INMODE LTD IS -01 Historical Marketcap From 2022 to 2026

Between 2022 and today, INMODE LTD IS -01's market cap moved from $2.44 Billion to $ 865.35 Million, with a yearly change of -23.90%.

Year Market Cap Change (%)
2026 €865.35 Million -5.37%
2025 €914.49 Million -22.78%
2024 €1.18 Billion -21.75%
2023 €1.51 Billion -37.88%
2022 €2.44 Billion --

End of Day Market Cap According to Different Sources

On May 4th, 2026 the market cap of INMODE LTD IS -01 was reported to be:

Source Market Cap
Yahoo Finance $834.35 Million USD
MoneyControl $834.35 Million USD
MarketWatch $834.35 Million USD
marketcap.company $834.35 Million USD
Reuters $834.35 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About INMODE LTD IS -01

F:154 Germany Medical Devices
Market Cap
$865.35 Million
€740.18 Million EUR
Market Cap Rank
#9944 Global
#1188 in Germany
Share Price
€11.71
Change (1 day)
-1.68%
52-Week Range
€11.02 - €13.88
All Time High
€41.52
About

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simulta… Read more